TempraMed begins trading on OTCQB Venture Market under TMPTF

• TempraMed uplisted its common shares to the OTCQB Venture Market for U.S. trading under TMPTF.
• DTC eligibility now in place, streamlining electronic clearing and settlement for U.S. investors.
• Canadian listing unchanged, with shares continuing to trade on the CSE under VIVI.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempramed Technologies Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607300700NEWSFILECNPR____20260730_307233_1) on July 30, 2026, and is solely responsible for the information contained therein.